vs
MIMEDX GROUP, INC.（MDXG）与Repay Holdings Corp（RPAY）财务数据对比。点击上方公司名可切换其他公司
MIMEDX GROUP, INC.的季度营收约是Repay Holdings Corp的1.5倍（$118.1M vs $78.6M），MIMEDX GROUP, INC.净利率更高（12.9% vs -178.3%，领先191.2%），MIMEDX GROUP, INC.同比增速更快（27.1% vs 0.4%），过去两年MIMEDX GROUP, INC.的营收复合增速更高（18.1% vs -1.3%）
MiMedx是一家总部位于美国佐治亚州玛丽埃塔的生物医疗企业，成立于2008年。该企业以胎盘、羊膜囊、脐带等分娩组织为原料，开发可用于植皮手术的医用真皮产品，在生物再生医疗领域开展业务。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商，为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案，涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具，助力客户简化交易流程、提升运营效率。
MDXG vs RPAY — 直观对比
营收规模更大
MDXG
是对方的1.5倍
$78.6M
营收增速更快
MDXG
高出26.7%
0.4%
净利率更高
MDXG
高出191.2%
-178.3%
两年增速更快
MDXG
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $118.1M | $78.6M |
| 净利润 | $15.2M | $-140.1M |
| 毛利率 | 83.9% | 74.2% |
| 营业利润率 | 17.8% | -182.2% |
| 净利率 | 12.9% | -178.3% |
| 营收同比 | 27.1% | 0.4% |
| 净利润同比 | 104.2% | -3304.1% |
| 每股收益（稀释后） | $0.10 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDXGRPAY
| Q4 25 | $118.1M | $78.6M | ||
| Q3 25 | $113.7M | $77.7M | ||
| Q2 25 | $98.6M | $75.6M | ||
| Q1 25 | $88.2M | $77.3M | ||
| Q4 24 | $92.9M | $78.3M | ||
| Q3 24 | $84.1M | $79.1M | ||
| Q2 24 | $87.2M | $74.9M | ||
| Q1 24 | $84.7M | $80.7M |
净利润MDXGRPAY
| Q4 25 | $15.2M | $-140.1M | ||
| Q3 25 | $16.7M | $-6.4M | ||
| Q2 25 | $9.6M | $-102.3M | ||
| Q1 25 | $7.0M | $-7.9M | ||
| Q4 24 | $7.4M | $-4.1M | ||
| Q3 24 | $8.1M | $3.2M | ||
| Q2 24 | $17.6M | $-4.1M | ||
| Q1 24 | $9.3M | $-5.2M |
毛利率MDXGRPAY
| Q4 25 | 83.9% | 74.2% | ||
| Q3 25 | 83.5% | 74.4% | ||
| Q2 25 | 81.1% | 75.7% | ||
| Q1 25 | 81.2% | 75.9% | ||
| Q4 24 | 81.8% | 76.3% | ||
| Q3 24 | 81.8% | 77.8% | ||
| Q2 24 | 83.0% | 78.2% | ||
| Q1 24 | 84.7% | 76.2% |
营业利润率MDXGRPAY
| Q4 25 | 17.8% | -182.2% | ||
| Q3 25 | 19.5% | -3.9% | ||
| Q2 25 | 12.5% | -138.7% | ||
| Q1 25 | 9.4% | -4.7% | ||
| Q4 24 | 11.9% | -1.5% | ||
| Q3 24 | 13.3% | -0.9% | ||
| Q2 24 | 26.9% | -4.6% | ||
| Q1 24 | 15.6% | -3.1% |
净利率MDXGRPAY
| Q4 25 | 12.9% | -178.3% | ||
| Q3 25 | 14.7% | -8.3% | ||
| Q2 25 | 9.8% | -135.2% | ||
| Q1 25 | 8.0% | -10.3% | ||
| Q4 24 | 8.0% | -5.3% | ||
| Q3 24 | 9.6% | 4.1% | ||
| Q2 24 | 20.2% | -5.4% | ||
| Q1 24 | 10.9% | -6.5% |
每股收益（稀释后）MDXGRPAY
| Q4 25 | $0.10 | $-1.68 | ||
| Q3 25 | $0.11 | $-0.08 | ||
| Q2 25 | $0.06 | $-1.15 | ||
| Q1 25 | $0.05 | $-0.09 | ||
| Q4 24 | $0.05 | $-0.04 | ||
| Q3 24 | $0.05 | $0.03 | ||
| Q2 24 | $0.12 | $-0.04 | ||
| Q1 24 | $0.06 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $166.1M | $115.7M |
| 总债务越低越好 | $18.0M | $280.1M |
| 股东权益账面价值 | $256.5M | $484.4M |
| 总资产 | $342.7M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.07× | 0.58× |
8季度趋势，按日历期对齐
现金及短期投资MDXGRPAY
| Q4 25 | $166.1M | $115.7M | ||
| Q3 25 | $142.1M | $95.7M | ||
| Q2 25 | $118.9M | $162.6M | ||
| Q1 25 | $106.4M | $165.5M | ||
| Q4 24 | $104.4M | $189.5M | ||
| Q3 24 | $88.8M | $168.7M | ||
| Q2 24 | $69.0M | $147.1M | ||
| Q1 24 | $48.5M | $128.3M |
总债务MDXGRPAY
| Q4 25 | $18.0M | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | $19.0M | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益MDXGRPAY
| Q4 25 | $256.5M | $484.4M | ||
| Q3 25 | $238.9M | $616.9M | ||
| Q2 25 | $216.6M | $633.7M | ||
| Q1 25 | $202.8M | $755.7M | ||
| Q4 24 | $193.1M | $761.3M | ||
| Q3 24 | $181.0M | $754.7M | ||
| Q2 24 | $168.0M | $815.4M | ||
| Q1 24 | $155.7M | $813.8M |
总资产MDXGRPAY
| Q4 25 | $342.7M | $1.2B | ||
| Q3 25 | $319.0M | $1.3B | ||
| Q2 25 | $291.1M | $1.4B | ||
| Q1 25 | $270.4M | $1.5B | ||
| Q4 24 | $263.9M | $1.6B | ||
| Q3 24 | $243.9M | $1.6B | ||
| Q2 24 | $230.2M | $1.5B | ||
| Q1 24 | $221.7M | $1.5B |
负债/权益比MDXGRPAY
| Q4 25 | 0.07× | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | 0.10× | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.0M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | — | $23.2M |
| 自由现金流率自由现金流/营收 | — | 29.6% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | 1.64× | — |
| 过去12个月自由现金流最近4个季度 | — | $90.7M |
8季度趋势，按日历期对齐
经营现金流MDXGRPAY
| Q4 25 | $25.0M | $23.3M | ||
| Q3 25 | $29.3M | $32.2M | ||
| Q2 25 | $14.4M | $33.1M | ||
| Q1 25 | $5.3M | $2.5M | ||
| Q4 24 | $18.8M | $34.3M | ||
| Q3 24 | $19.6M | $60.1M | ||
| Q2 24 | $21.8M | $31.0M | ||
| Q1 24 | $6.0M | $24.8M |
自由现金流MDXGRPAY
| Q4 25 | — | $23.2M | ||
| Q3 25 | — | $32.1M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $2.4M | ||
| Q4 24 | — | $34.0M | ||
| Q3 24 | — | $59.8M | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率MDXGRPAY
| Q4 25 | — | 29.6% | ||
| Q3 25 | — | 41.3% | ||
| Q2 25 | — | 43.6% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 43.5% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度MDXGRPAY
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.2% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.6% | ||
| Q1 24 | — | 0.1% |
现金转化率MDXGRPAY
| Q4 25 | 1.64× | — | ||
| Q3 25 | 1.75× | — | ||
| Q2 25 | 1.50× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 2.53× | — | ||
| Q3 24 | 2.42× | 18.52× | ||
| Q2 24 | 1.24× | — | ||
| Q1 24 | 0.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDXG
| Wound | $78.7M | 67% |
| Surgical | $39.4M | 33% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
